207 related articles for article (PubMed ID: 1933441)
1. Effect of a nonpeptide angiotensin II receptor antagonist, DuP 753, on angiotensin-related water intake in rats.
Fregly MJ; Rowland NE
Brain Res Bull; 1991 Jul; 27(1):97-100. PubMed ID: 1933441
[TBL] [Abstract][Full Text] [Related]
2. Effects of a non-peptide angiotensin receptor antagonist on drinking and blood pressure responses to centrally administered angiotensins in the rat.
Kirby RF; Thunhorst RL; Johnson AK
Brain Res; 1992 Apr; 576(2):348-50. PubMed ID: 1515929
[TBL] [Abstract][Full Text] [Related]
3. Effect of DuP 753, a nonpeptide angiotensin II receptor antagonist, on the drinking responses to acutely administered dipsogenic agents in rats.
Fregly MJ; Rowland NE
Proc Soc Exp Biol Med; 1992 Feb; 199(2):158-64. PubMed ID: 1311103
[TBL] [Abstract][Full Text] [Related]
4. Effect of Losartan, a nonpeptide angiotensin II receptor antagonist, on drinking behavior and renal actions of centrally administered renin.
Barbella Y; Cierco M; Israel A
Proc Soc Exp Biol Med; 1993 Apr; 202(4):401-6. PubMed ID: 8456103
[TBL] [Abstract][Full Text] [Related]
5. The role of angiotensin, AT1 and AT2 receptors in the pressor, drinking and vasopressin responses to central angiotensin.
Hogarty DC; Speakman EA; Puig V; Phillips MI
Brain Res; 1992 Jul; 586(2):289-94. PubMed ID: 1521162
[TBL] [Abstract][Full Text] [Related]
6. Effect of nonpeptide angiotensin receptor antagonists on water intake and salt appetite in rats.
Rowland NE; Rozelle A; Riley PJ; Fregly MJ
Brain Res Bull; 1992; 29(3-4):389-93. PubMed ID: 1393612
[TBL] [Abstract][Full Text] [Related]
7. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
Wienen W; Mauz AB; Van Meel JC; Entzeroth M
Mol Pharmacol; 1992 Jun; 41(6):1081-8. PubMed ID: 1614410
[TBL] [Abstract][Full Text] [Related]
8. AT1 angiotensin receptors mobilize intracellular calcium in a subclone of NG108-15 neuroblastoma cells.
Ransom JT; Sharif NA; Dunne JF; Momiyama M; Melching G
J Neurochem; 1992 May; 58(5):1883-8. PubMed ID: 1560241
[TBL] [Abstract][Full Text] [Related]
9. Brain angiotensin AT-2 receptor antagonism and water intake.
Rowland NE; Fregly MJ
Brain Res Bull; 1993; 32(4):391-4. PubMed ID: 8221129
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of DUP-753 on the drinking responses of rats to central administration of noradrenaline and angiotensin II and to dehydration.
Reis LC; Saad WA; Camargo LA; Renzi A; Menani V; Silveira JE; Saad WA
Braz J Med Biol Res; 1996 Apr; 29(4):507-10. PubMed ID: 8736116
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II and III microinjections into the zona incerta influence drinking behavior.
Bagi EE; Fekete E; Lénárd L
Brain Res; 2003 Jul; 977(2):199-208. PubMed ID: 12834880
[TBL] [Abstract][Full Text] [Related]
12. Non-peptide angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor: effect on a renin-induced deficit of a passive avoidance response in rats.
DeNoble VJ; DeNoble KF; Spencer KR; Chiu AT; Wong PC; Timmermans PB
Brain Res; 1991 Oct; 561(2):230-5. PubMed ID: 1802340
[TBL] [Abstract][Full Text] [Related]
13. Access of peripherally administered DuP 753 to rat brain angiotensin II receptors.
Song KF; Zhuo JL; Mendelsohn FA
Br J Pharmacol; 1991 Dec; 104(4):771-2. PubMed ID: 1810594
[TBL] [Abstract][Full Text] [Related]
14. Effect of losartan potassium and deoxycorticosterone acetate on tail skin temperature response to acute administration of angiotensin II.
Fregly MJ; Rowland NE
Pharmacol Biochem Behav; 1992 Sep; 43(1):229-33. PubMed ID: 1472262
[TBL] [Abstract][Full Text] [Related]
15. Intravenous losartan inhibits the increase in plasma luteinizing hormone and water intake produced by intraventricular angiotensin II.
Palmer AA; Steele MK; Shackelford RL; Ganong WF
Proc Soc Exp Biol Med; 1994 Mar; 205(3):263-6. PubMed ID: 8171048
[TBL] [Abstract][Full Text] [Related]
16. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2).
Wong PC; Hart SD; Zaspel AM; Chiu AT; Ardecky RJ; Smith RD; Timmermans PB
J Pharmacol Exp Ther; 1990 Nov; 255(2):584-92. PubMed ID: 2243344
[TBL] [Abstract][Full Text] [Related]
17. Intracerebroventricular administration of angiotensin II increases heart rate in the conscious trout.
Le Mevel JC; Pamantung TF; Mabin D; Vaudry H
Brain Res; 1994 Aug; 654(2):216-22. PubMed ID: 7987671
[TBL] [Abstract][Full Text] [Related]
18. The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism.
Ohlstein EH; Gellai M; Brooks DP; Vickery L; Jugus J; Sulpizio A; Ruffolo RR; Weinstock J; Edwards RM
J Pharmacol Exp Ther; 1992 Aug; 262(2):595-601. PubMed ID: 1501114
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
[TBL] [Abstract][Full Text] [Related]
20. Drinking induced by subcutaneous injection of angiotensin II in the rat is blocked by the selective AT1 receptor antagonist DuP 753 but not by the selective AT2 receptor antagonist WL 19.
Dourish CT; Duggan JA; Banks RJ
Eur J Pharmacol; 1992 Jan; 211(1):113-6. PubMed ID: 1618259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
